Mannkind (MNKD) Operating Expenses (2010 - 2026)
Mannkind (MNKD) posted quarterly Operating Expenses of $91.8 million for Q1 2026, up 63.82% year-over-year from $56.1 million in Q1 2025, and down 23.24% quarter-over-quarter from $119.6 million in Q4 2025.
Mannkind (MNKD) Operating Expenses (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Operating Expenses for 17 consecutive years, with $91.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 63.82% year-over-year to $91.8 million; the TTM figure through Mar 2026 stood at $345.9 million (up 57.65% YoY), while the FY2025 annual figure was $310.2 million, up 45.67% from the prior year.
- Operating Expenses declined to $91.8 million in Q1 2026 per MNKD's latest filing, from $119.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $119.6 million in Q4 2025 and bottomed at $33.2 million in Q1 2022.
- Historically, Operating Expenses has averaged $57.0 million across 5 years, with a median of $50.3 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses decreased 0.66% — and 2025, when it surged 137.95%.
- Mannkind's Operating Expenses stood at $48.8 million in 2022, then increased by 3.61% to $50.6 million in 2023, then slipped by 0.66% to $50.3 million in 2024, then soared by 137.95% to $119.6 million in 2025, then fell by 23.24% to $91.8 million in 2026.
- Business Quant data shows MNKD's Operating Expenses at $91.8 million in Q1 2026, $119.6 million in Q4 2025, and $63.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 109.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.72 Mn |
| Mar 31, 2026 | 91.84 Mn |
| Dec 31, 2025 | 119.64 Mn |
| Sep 30, 2025 | 63.23 Mn |
| Jun 30, 2025 | 71.23 Mn |
| Mar 31, 2025 | 56.06 Mn |
| Dec 31, 2024 | 50.28 Mn |
| Sep 30, 2024 | 57.32 Mn |
| Jun 30, 2024 | 55.78 Mn |
| Mar 31, 2024 | 49.54 Mn |
| Dec 31, 2023 | 50.61 Mn |
| Sep 30, 2023 | 46.16 Mn |
| Jun 30, 2023 | 46.89 Mn |
| Mar 31, 2023 | 46.62 Mn |
| Dec 31, 2022 | 48.85 Mn |
| Sep 30, 2022 | 42.44 Mn |
| Jun 30, 2022 | 39.35 Mn |
| Mar 31, 2022 | 33.25 Mn |
| Dec 31, 2021 | 36.48 Mn |
| Sep 30, 2021 | 28.80 Mn |